Method and composition for pharmaceutical product
US8871271B2 · kind B2 · utility
3Cited by
77References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 29, 2013 |
| Grant date | Oct 28, 2014 |
| Priority date | — |
| Expiry date | Jul 29, 2033 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/1694
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention is directed to a composition comprising dry granulated tenofovir DF and emtricitabine, and a method for making same. Dry granulation was unexpectedly found to be important in preparing a tenofovir DF containing composition suitable for inclusion in a combination dosage form containing emtricitabine, efavirenz and tenofovir DF.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.